144 related articles for article (PubMed ID: 25581050)
1. Scientific evidence shows the need for a fresh approach to IVF.
Nargund G
Womens Health (Lond); 2015 Jan; 11(1):11-3. PubMed ID: 25581050
[No Abstract] [Full Text] [Related]
2. Mild stimulation for in vitro fertilization.
Nargund G; Datta AK; Fauser BCJM
Fertil Steril; 2017 Oct; 108(4):558-567. PubMed ID: 28965549
[TBL] [Abstract][Full Text] [Related]
3. Poor response--the devil is in the definition.
Turhan NO
Fertil Steril; 2006 Sep; 86(3):777; author reply 777. PubMed ID: 16952530
[No Abstract] [Full Text] [Related]
4. Middle cerebral artery thrombosis after IVF and ovarian hyperstimulation: a case report.
Jing Z; Yanping L
Fertil Steril; 2011 Jun; 95(7):2435.e13-5. PubMed ID: 21601668
[TBL] [Abstract][Full Text] [Related]
5. Friendly IVF: the way of the future?
Olivennes F; Frydman R
Hum Reprod; 1998 May; 13(5):1121-4. PubMed ID: 9647528
[No Abstract] [Full Text] [Related]
6. Antagonist rescue of agonist IVF cycle at risk of OHSS: a case series.
Martínez F; Mancini F; Solé M; José Gomez M; Beatriz Rodríguez D; Buxaderas R; Rodriguez I; Nolasc Barri P
Gynecol Endocrinol; 2014 Feb; 30(2):145-8. PubMed ID: 24266696
[TBL] [Abstract][Full Text] [Related]
7. [Minimal ovarian stimulation: certainly less dangerous but rarely as efficient].
Antoine JM; Verstraete L
Gynecol Obstet Fertil; 2006 Apr; 34(4):356-7. PubMed ID: 16564729
[No Abstract] [Full Text] [Related]
8. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.
Gao MZ; Zhao XM; Sun ZG; Hong Y; Zhao LW; Zhang HQ
Fertil Steril; 2011 Feb; 95(2):673-8. PubMed ID: 21067720
[TBL] [Abstract][Full Text] [Related]
9. Is ovarian hyperstimulation associated with higher blood pressure in 4-year-old IVF offspring? Part I: multivariable regression analysis.
Seggers J; Haadsma ML; La Bastide-Van Gemert S; Heineman MJ; Middelburg KJ; Roseboom TJ; Schendelaar P; Van den Heuvel ER; Hadders-Algra M
Hum Reprod; 2014 Mar; 29(3):502-9. PubMed ID: 24365797
[TBL] [Abstract][Full Text] [Related]
10. The use of aromatase inhibitors in in vitro fertilization.
Garcia-Velasco JA
Fertil Steril; 2012 Dec; 98(6):1356-8. PubMed ID: 23062732
[TBL] [Abstract][Full Text] [Related]
11. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
12. What is new in IVF?
Kovacs GT
Med J Aust; 2014 Sep; 201(5):244-5. PubMed ID: 25163360
[No Abstract] [Full Text] [Related]
13. [Controlled ovarian hyperstimulation in an in vitro fertilization program. Results and prevention of complications].
Grochowski D
Ginekol Pol; 2000 Oct; 71(10):1293-6. PubMed ID: 11143940
[No Abstract] [Full Text] [Related]
14. Thrombosis following ovarian hyperstimulation syndrome.
Kasum M; Danolić D; Orešković S; Ježek D; Beketić-Orešković L; Pekez M
Gynecol Endocrinol; 2014 Nov; 30(11):764-8. PubMed ID: 25014487
[TBL] [Abstract][Full Text] [Related]
15. [IVF in a modified natural cycle].
Bos AM; Pelinck MJ; Dumoulin JC; Arts EG; van Echten-Arends J; Simons AH
Ned Tijdschr Geneeskd; 2010; 154(45):A2519. PubMed ID: 21118595
[TBL] [Abstract][Full Text] [Related]
16. Short and long-term risks to women who conceive through in vitro fertilization.
Gelbaya TA
Hum Fertil (Camb); 2010 Mar; 13(1):19-27. PubMed ID: 19929571
[TBL] [Abstract][Full Text] [Related]
17. Heterotopic triplet pregnancy complicated with ovarian hyperstimulation syndrome following in vitro fertilization.
Tomić V; Tomić J; Kuna K; Zigmundovac-Klaić D
Acta Clin Croat; 2011 Dec; 50(4):595-8. PubMed ID: 22649892
[TBL] [Abstract][Full Text] [Related]
18. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr.
Arslan M; Bocca S; Mirkin S; Barroso G; Stadtmauer L; Oehninger S
Fertil Steril; 2005 Sep; 84(3):555-69. PubMed ID: 16169382
[TBL] [Abstract][Full Text] [Related]
19. Avoiding ovarian hyperstimulation syndrome with the use of gonadotropin-releasing hormone agonist trigger.
Fatemi HM; Garcia-Velasco J
Fertil Steril; 2015 Apr; 103(4):870-3. PubMed ID: 25724740
[TBL] [Abstract][Full Text] [Related]
20. [Some aspects of ovarian hyperstimulation syndrome].
Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
